Pharma Pulse 6/30/25: Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research

Preparing for Federal Regulations: Q&A with John Stanford

In an interview with Pharmaceutical Executive, John Stanford, executive director at Incubate, emphasized the importance of sustained investment in early-stage biotech to drive long-term innovation and ensure a robust drug development pipeline.

Funding Cuts Threaten Diversity in Clinical Research

In an interview with Applied Clinical Trials, Kyle McAllister, co-founder and CEO of Trially, warned that funding cuts to clinical research threaten diversity by undermining support for studies focused on underrepresented populations and stressed that technologies such as artificial intelligence and telemedicine are vital to mitigating these challenges.

Help Patients Prevent and Treat Dry Mouth

Health care professionals can help patients prevent and manage dry mouth by identifying potential medication-related causes, recommending lifestyle changes and over-the-counter products with ingredients like xylitol, and emphasizing good oral hygiene practices to reduce the risk of dental complications.

Q&A: Expert Discusses the Critical Role of Clinical Pharmacists in Diabetes Management

Nathan Ramsbacher, PharmD, emphasized the vital role of clinical pharmacists in diabetes management by improving medication access through manufacturer-sponsored patient assistance programs, resulting in significant cost savings and better health outcomes for patients.

Supreme Court Preserves Key Part of Obamacare Coverage Requirements

The Supreme Court upheld a key provision of the Affordable Care Act requiring private insurers to cover preventive health services, rejecting a constitutional challenge and preserving access to no-cost care—such as cancer screenings and HIV prevention—for roughly 150 million Americans.